Conflict of interest
Johnson & Johnson)
M.M.: research grants (AbbVie, MSD, Ono Pharmaceutical, AstraZeneca). K.I.: speakers’ bureau (AstraZeneca); research grants (AbbVie Inc, Takeda Pharmaceutical, Ono Pharmaceutical). H.N.: research grants (AbbVie, AstraZeneca, Takeda Pharmaceutical). H.K.: research grants (AbbVie); donations (Chugai Pharmaceutical). S.K.: manuscript fees and other (Kinpodo, Johnson & Johnson); research grants (AbbVie GK, Merck, Genmab, Clovis, AstraZeneca, Zeria Pharmaceutical). K.U.: research grants (AbbVie, Chugai, AstraZeneca, Pfizer, Takeda Pharmaceutical, Kaken Pharmaceutical, Nippon Kayaku, Taiho Pharmaceutical, Eisai, Mochida Pharmaceutical, Ono Pharmaceutical, MSD, Tsumura Pharmaceuticals); speakers’ bureau (Chugai, AstraZeneca, Kyowa Kirin, Bayer, Tsumura Pharmaceuticals, MSD). Sh.Na.: speakers’ bureau (Chugai Pharmaceutical, Mochida Pharmaceutical, Asahi Kasei Medical, Terumo Corporation); research grants (AbbVie, Takeda Pharmaceutical, Pfizer, AstraZeneca, Taiho Pharmaceutical). Hi.Ta.: research grants (AbbVie). M.O.: research grants (AbbVie). M.T.: research grants (AbbVie, Takeda Pharmaceutical, Chugai Pharmaceutical, MSD). Hi.To.: Research grants (AbbVie). Sa.Na.: Speakers’ bureau (Chugai Pharmaceutical, AstraZeneca); research grants (AbbVie, Ono Pharmaceutical). D.A.: speakers’ bureau (AbbVie, AstraZeneca, Chugai Pharmaceutical, MSD, Myriad Genetics, Takeda Pharmaceutical); consultancy (AstraZeneca, Chugai Pharmaceutical, MSD, Myriad Genetics, Takeda Pharmaceutical); research grants (AbbVie, Takeda Pharmaceutical). R.L.C.: research grants (Merck, AstraZeneca, Roche, AbbVie, Esperance, Clovis, Gateway, V Foundation); scientific steering committee (AbbVie, AstraZeneca, Clovis, GamaMabs, Genmab, ImmunoGen, Janssen, Merck, Roche/Genentech, GSK, Gradalis). Y.N., C.R., H.H., and H.X.: employees of AbbVie and may hold stock or stock options. N.K.: research grants (AbbVie). T.E.: speakers’ bureau (AstraZeneca, MSD, Chugai). A.O.: speakers’ bureau (Takeda Pharmaceutical Company Ltd., Zeria Pharmaceutical Co., Ltd., AstraZeneca K.K., Eisai Co., Ltd., Kaken Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., Bayer Holding Ltd., ASKA Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., MSD K.K., Fuji Pharma Co., Ltd.); research grants (Meiji Holdings Co., Ltd., Fuji Pharma Co., Ltd., Taiho Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Kaken Pharmaceutical Co., Ltd., Nippon Shinyaku Co., Ltd., ASKA Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd.).